newsfilter
← Latest News
PR Newswire·

WuXi Biologics and Vertex Sign License and Research Service Agreement for T-cell Engager

WuXi Biologics (2269. HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), today announced that it has...